SEARCH

SEARCH BY CITATION

References

  • ANSELMI, K., SUBBOTIN, V.M., NEMOTO, E. & GANDHI, C.R. (2002). Accelerated reversal of carbon tetrachloride-induced cirrhosis in rats by endothelin receptor antagonist TAK-044. J. Gastroenterol. Hepatol., 17, 589597.
  • BENIGNI, A. (2000). Endothelin antagonists in renal disease. Kidney Int., 57, 17781794.
  • BRINCKERHOFF, C.E., COFFEY, J.W. & SULLIVAN, A.C. (1983). Inflammation and collagenase production in rats with adjuvant arthritis reduced with 13-cis-retinoic acid. Science, 221, 756758.
  • DAVIS, B.H. (1988). Transforming growth factor β responsiveness is modulated by the extracellular collagen matrix during hepatic Ito cell culture. J. Cell. Physiol., 136, 547553.
  • DAVIS, B.H., PRATT, B.M. & MADRI, J. (1988). Retinol and extracellular collagen matrices modulate hepatic Ito cell collagen phenotype and cellular retinol binding protein levels. J. Biol. Chem., 262, 1028010286.
  • DAVIS, B. & VUCIC, A. (1988). The effect of retinol on Ito cell proliferation in vitro. Hepatology, 8, 788793.
  • DAVIS, B. & VUCIC, A. (1989). Modulation of vitamin A metabolism during hepatic and intestinal cell culture. Biochim. Biophys. Acta, 1010, 318324.
  • DAVIS, B.H., KRAMER, R.T. & DAVIDSON, N.O. (1990). Retinoic acid modulates rat Ito cell proliferation, collagen and transforming growth factor β production. J. Clin. Invest., 86, 20622070.
  • DAVIS, B.H., RAPP, U.R. & DAVIDSON, N.O. (1991). Retinoic acid and transforming growth factor β differentially inhibit platelet-derived growth factor-induced Ito-cell activation. Biochem. J., 278, 4347.
  • FRIEDMAN, S.L. (2000). Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem., 275, 22472250.
  • FRIEDMAN, S.L. & BLANER, W.S. (1989). Activation of cultured lipocytes by Kupffer cell medium (KCM) is accompanied by release of retinol. Gastroenterology, 96, A598.
  • FUMARULO, R., CONESE, M., RICCARDI, S., GIORDANO, D., MONTEMURO, P., GOLUCCI, M. & SEMERARO, N. (1991). Retinoids inhibit the respiratory burst and degranulation of stimulated human polymorphonuclear leukocytes. Agents Actions, 34, 339342.
  • GABRIEL, A., KUDDUS, R.H., RAO, A.S. & GANDHI, C.R. (1999). Down-regulation of endothelin receptors by transforming growth factor β1 in hepatic stellate cells. J. Hepatol., 30, 440450.
  • GANDHI, C.R., KANG, Y., MADARIAGA, J., AGGARWAL, S., DE WOLF, A., SCOTT, V. & FUNG, J. (1996a). Altered endothelin homeostasis in patients undergoing liver transplantation. Liver Transplant. Surg., 2, 362369.
  • GANDHI, C.R., KUDDUS, R.H., UEMURA, T. & RAO, A.S. (2000). Endothelin stimulates transforming growth factor-β1 and collagen synthesis in stellate cells from control but not cirrhotic rat liver. Eur. J. Pharmacol., 406, 311318.
  • GANDHI, C.R., NEMOTO, E.M., WATKINS, S.C. & SUBBOTIN, V.M. (1998). An endothelin receptor antagonist TAK- 044 ameliorates carbon tetrachloride-induced acute liver injury and portal hypertension in rats. Liver, 18, 3948.
  • GANDHI, C.R., SPROAT, L.A. & SUBBOTIN, V.M. (1996b). Increased hepatic endothelin-1 levels and endothelin receptor density in cirrhotic rats. Life Sci., 58, 5562.
  • GANDHI, C.R., STEPHENSON, K. & OLSON, M.S. (1990). Endothelin, a potent peptide agonist in the liver. J. Biol. Chem., 265, 1743217435.
  • GEERTS, A., DEBLESER, P., HAUTEKEETE, M.L., NIKI, T. & WISSE, E. (1994). Fat-storing (Ito) cell biology. In: The Liver: Biology and Pathobiology. ed. Arias, I.M., Boyer, J.L., Fasuto, N., Jakoby, W.B., Schachter, D.L. & Shafritz, D.A. pp. 819838. New York: Raven Press, Ltd.
  • GEERTS, A., VRIJSEN, R., RAUTERBERG, A., BURT, P., SCHELLINCK, P. & WISSE, E. (1989a). In vitro differentiation of fat-storing cells parallels marked increase of collagen synthesis and secretion. J. Hepatol., 9, 5968.
  • GEERTS, A., VRIJSEN, R., SCHELLINCK, P. & WISSE, E. (1989b). Retinol affects the phenotype and protein synthesis of fat-storing cell derived myofibroblasts in vitro. In: Cells of Hepatic Sinusoids. ed. Wisse, E., Knook, D. & Decker, K. Vol. 2, pp. 2024. Rijswijk, The Netherlands: Kupffer Cell Foundation.
  • HOCHER, B., THONE-REINEKE, T., ROHMEISS, P., SCHMAGER, F., SLOWINSKI, T., BURST, V., SIEGMUND, F., QUERTERMOUS, T., BAUER, C., NEUMAYER, H., SCHLEUNING, W. & THEURING, F. (1997). Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J. Clin. Invest., 99, 13801389.
  • HOUSSET, C., ROCKEY, D.C. & BISSELL, D.M. (1993). Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. Proc. Natl. Acad. Sci. U.S.A., 90, 92669270.
  • HSU, J.-Y. & PFAHL, M. (1998). ET-1 expression and growth inhibition of prostrate cancer cells: a retinoid target with novel specificity. Cancer Res., 58, 48174822.
  • KAWADA, N., TRAN-THI, T.A., KLEIN, H. & DECKER, K. (1993). The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur. J. Biochem., 213, 815823.
  • KUDDUS, R.H., NALESNIK, M.A., SUBBOTIN, V.M., RAO, A.S. & GANDHI, C.R. (2000). Enhanced synthesis and reduced metabolism of endothelin-1 (ET-1) by hepatocytes: a mechanism of increased ET-1 levels in cirrhosis. J. Hepatol., 33, 725732.
  • LEO, M.A. & LIEBER, C.S. (1988). Hypervitaminosis A: a liver lover's lament. Hepatology, 8, 412417.
  • MALLAT, A., PREAUX, A.M., SERRADEIL-LE GAL, C., RAUFASTE, D., GALLOIS, C., BRENNER, D.A., BRADHAM, C., MACLOUF, J., IOURGENKO, V., FOUASSIER, L., DHUMEAUX, D., MAVIER, P. & LOTERSZTAJN, S. (1996). Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptors. J. Clin. Invest., 98, 27712778.
  • ORFANOS, C.E. & BAUER, R. (1983). Evidence for antiinflammatory activities of oral synthetic retinoids: experimental findings and clinical experience. Br. J. Dermatol., S25, 5560.
  • PINZANI, M. & ABBOUD, H.E. (1991). Liver fat-storing cells, polypeptide growth factors and the progression of chronic liver inflammation and fibrosis. In: Experimental and Clinical Hepatology. ed. Gentilini, P. & Dianzani, M.U. pp. 6375. Amsterdam: Elsevier.
  • PINZANI, M., GENTILINI, P. & ABBOUD, H.E. (1992a). Phenotypical modulation of fat-storing cells by retinoids. Influence on unstimulated and growth factor-induced cell proliferation. J. Hepatol., 14, 211220.
  • PINZANI, M., FAILLI, P., RUOCCO, C., CASINI, A., MILANI, S., BALDI, E., GIOTTI, A. & GENTILINI, P. (1992b). Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients. J. Clin. Invest., 90, 642646.
  • PINZANI, M., MILANI, S., DE FRANCO, R., GRAPPONE, C., CALIGIURI, A., GENTILINI, A., TOSTI-GUERRA, C., MAGGI, M., FAILLI, P., RUOCCO, C. & GENTILINI, P. (1996). Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology, 110, 534548.
  • RAGO, R., MITCHEN, J. & WILDING, G. (1990). DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water. Anal. Biochem., 191, 3134.
  • ROCKEY, D.C. (1995). Characterization of endothelin receptors mediating rat hepatic stellate cell contraction. Biochem. Biophys. Res. Commun., 207, 725731.
  • ROCKEY, D.C. & CHUNG, J.J. (1996). Endothelin antagonism in experimental hepatic flbrosis. Implications for endothelin in the pathogenesis of wound healing. J. Clin. Invest., 98, 13811388.
  • SHINA, S., SHIRATORI, Y., KAWASE, T. & SUGIMOTO, T. (1989). Increased collagen synthesis by fat-storing cells exposed to superoxide- possible mechanism of hepatic fibrosis during inflammation. In: Cells of Hepatic Sinusoids. ed. Wisse, E., Knook, D.L. & Decker, K. Vol. 2, pp. 5256. Rijswijk, The Netherlands: Kupffer Cell Foundation.
  • SHIRATORI, Y., GEERTS, A., ICHIDA, T., KAWASE, T. & WISSE, E. (1986). Kupffer cells from CCl4-induced fibrotic livers stimulate proliferation of fat-storing cells. J. Hepatol., 3, 294303.
  • SHIRATORI, Y., ICHIDA, T., GEERTS, A. & WISSE, E. (1987). Modulation of collagen synthesis by fat-storing cells, isolated from CCl4- or vitamin A-treated rats. Dig. Dis. Sci., 32, 12811289.
  • TAKASE, S., ENYAMA, K., TAKADA, A. & TSUTSUMI, M. (1992). Effects of vitamin A on collagen metabolism by cultured rat liver cells. Gastroenterol. Jpn., 27, 354363.
  • TANG, G.W. & RUSSELL, R.M. (1990). 13-cis-retinoic acid is an endogenous compound in human serum. J. Lipid Res., 31, 175182.
  • TEDER, P. & NOBLE, P.W. (2000). A cytokine reborn? Endothelin-1 in pulmonary inflammation and fibrosis. Am. J. Respir. Cell. Mol. Biol., 23, 710.
  • UEMURA, T. & GANDHI, C.R. (2001). Inhibition of DNA synthesis in cultured hepatocytes by endotoxin-conditioned medium of activated stellate cells is transforming growth factor-β- and nitric oxide-independent. Br. J. Pharmacol., 133, 11251133.
  • WEBER, K.T., SUN, Y. & GUARDA, E. (1994). Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension, 23, 869877.
  • ZHANG, J.X., BAUER, M. & CLEMENS, M.G. (1995). Vessel- and target cell-specific actions of endothelin-1 and endothelin-3 in rat liver. Am. J. Physiol., 269, G269G277.